BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics
September 17, 2025
FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke's Hospital of the University of Cambridge, United Kingdom. Together with its comprehensive menu of assays for DNA, RNA, and protein [...]
September 17, 2025
Tempe, AZ -- Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR microscopy technology first launched in 2017, the SPRm 220 brings enhanced throughput, improved usability, and unmatched capability in label-free, cell-based kinetic analysis. Designed specifically for the challenges of membrane protein research, [...]
September 17, 2025
Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has announced the launch of its Microbial Amplicon Barcoding Kit 24 V14, to enable faster and more flexible microbial analysis in a single workflow. Oxford Nanopore’s new kit has been optimised to provide an information-rich, rapid, and accessible full-length amplicon [...]
September 17, 2025
RiboMarker-NextGen Biomarker Discovery SANTA CRUZ, CA, UNITED STATES -- RealSeq Biosciences, a pioneer in RNA-based diagnostics, today announced it has received a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) (FAIN# R44HG013284; Federal Award Date: August 15, 2025). This highly competitive award provides multi-year, non-dilutive funding to accelerate [...]
September 16, 2025
New formats redefine molecular assay development by cutting refrigeration costs, simplifying logistics, and ensuring uncompromised performance at room temperature. CINCINNATI -- The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of the industry's first liquid qPCR master mixes proven stable for over [...]
Causaly Introduces First Agentic AI Platform Built for Life Sciences Research and Development
September 16, 2025
Specialized AI agents automate research workflows and accelerate drug discovery and development with transparent, evidence-backed insights LONDON – Causaly today introduced Causaly Agentic Research, an agentic AI breakthrough that delivers the transparency and scientific rigor that life sciences research and development demands. First-of-their-kind, specialized AI agents access, analyze, and synthesize comprehensive internal and external biomedical [...]
HIGH Q TECHNOLOGIES INTRODUCES EPR SAMPLE MEASUREMENT SERVICE TO ADVANCE PROTEIN STRUCTURE RESEARCH
September 16, 2025
WATERLOO, ON - High Q Technologies, an innovative manufacturer of quantum-enabled Electron Paramagnetic Resonance (EPR) spectrometers, announced the launch of the High Q Sample Measurement Service today. Aimed at the structural biology community, High Q's new measurement service will enable researchers in academia and the pharmaceutical industry to access information about the molecular dynamics and [...]
Sapio Sciences Introduces World’s First 3rd-Generation ELN
September 16, 2025
Sapio ELaiN is an agentic, AI–powered notebook where scientists collaborate directly with an AI co-scientist BALTIMORE -- Sapio Sciences, the science-awareTM AI lab informatics platform, today announced the launch of the world’s first 3rd-generation Electronic Lab Notebook (ELN) that thinks like a scientist, Sapio ELaiN. As the first AI Laboratory Notebook (AILN), Sapio ELaiN accelerates biopharma R&D by [...]
Maria Rankka appointed Board Chair of BICO Group AB
September 16, 2025
The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders’ meeting. Maria Rankka succeeds Rolf Classon who, for health reasons, has chosen to resign from his position on the board and as [...]
Scientist.com Announces Agreement to Be Acquired by GHO Capital Partners
September 16, 2025
Strategic partnership accelerates the company’s mission to transform pharmaceutical R&D Solana Beach, CA — Scientist.com, the leading AI-enabled R&D orchestration platform for the life sciences industry, today announced that it has entered into a definitive agreement to be acquired by GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare. This milestone transaction validates [...]

